Nicholas James Ashton
Nicholas James Ashton
University of Gothenburg / King's College London
Verified email at
Cited by
Cited by
Plasma proteins predict conversion to dementia from prodromal disease
A Hye, J Riddoch-Contreras, AL Baird, NJ Ashton, C Bazenet, R Leung, ...
Alzheimer's & Dementia 10 (6), 799-807. e2, 2014
Steroid‐responsive encephalitis in Covid‐19 disease
A Pilotto, SI Odolini, S Stefano Masciocchi, A Comelli, I Volonghi, ...
Annals of Neurology, 2020
Biomarkers for tau pathology
M Schöll, A Maass, N Mattsson, NJ Ashton, K Blennow, H Zetterberg, ...
Molecular and Cellular Neuroscience 97, 18-33, 2019
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
NJ Ashton, A Leuzy, YM Lim, C Troakes, T Hortobágyi, K Höglund, ...
Acta neuropathologica communications 7 (1), 1-11, 2019
Blood protein predictors of brain amyloid for enrichment in clinical trials?
NJ Ashton, SJ Kiddle, J Graf, M Ward, AL Baird, A Hye, S Westwood, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (1), 48-60, 2015
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ...
The Lancet Neurology 19 (5), 422-433, 2020
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19
N Kanberg, NJ Ashton, LM Andersson, A Yilmaz, M Lindh, S Nilsson, ...
Neurology 95 (12), e1754-e1759, 2020
Blood-based biomarker candidates of cerebral amyloid using PiB PET in non-demented elderly
S Westwood, E Leoni, A Hye, S Lynham, MR Khondoker, NJ Ashton, ...
Journal of Alzheimer's Disease 52 (2), 561-572, 2016
Plasma protein biomarkers of Alzheimer’s disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes
SJ Kiddle, CJ Steves, M Mehta, A Simmons, X Xu, S Newhouse, ...
Translational psychiatry 5 (6), e584-e584, 2015
Finding a pathological diagnosis for A lzheimer's disease: Are inflammatory molecules the answer?
MS Bhamra, NJ Ashton
Electrophoresis 33 (24), 3598-3607, 2012
No association of salivary total tau concentration with Alzheimer's disease
NJ Ashton, M Ide, M Schöll, K Blennow, S Lovestone, A Hye, H Zetterberg
Neurobiology of aging 70, 125-127, 2018
Update on biomarkers for amyloid pathology in Alzheimer's disease
NJ Ashton, M Schöll, K Heurling, E Gkanatsiou, E Portelius, K Höglund, ...
Biomarkers in medicine 12 (7), 799-812, 2018
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
NJ Ashton, AJ Nevado-Holgado, IS Barber, S Lynham, V Gupta, ...
Science advances 5 (2), eaau7220, 2019
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
CM Startin, NJ Ashton, S Hamburg, R Hithersay, FK Wiseman, KY Mok, ...
Alzheimer's research & therapy 11 (1), 26, 2019
Plasma REST: A novel candidate biomarker of Alzheimer’s disease is modified by psychological intervention in an at-risk population
NJ Ashton, A Hye, CA Leckey, AR Jones, A Gardner, C Elliott, ...
Translational psychiatry 7 (6), e1148-e1148, 2017
Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins
N Voyle, M Kim, P Proitsi, NJ Ashton, AL Baird, C Bazenet, A Hye, ...
Translational psychiatry 6 (1), e719-e719, 2016
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead
J Simrén, NJ Ashton, K Blennow, H Zetterberg
Current Opinion in Neurobiology 61, 29-39, 2020
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid‐positive individuals
AL Benedet, NJ Ashton, TA Pascoal, A Leuzy, S Mathotaarachchi, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11 (1 …, 2019
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease …
M Kim, S Snowden, T Suvitaival, A Ali, DJ Merkler, T Ahmad, S Westwood, ...
Alzheimer's & Dementia 15 (6), 817-827, 2019
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
NJ Ashton, A Hye, AP Rajkumar, A Leuzy, S Snowden, M Suárez-Calvet, ...
Nature Reviews Neurology, 1-20, 2020
The system can't perform the operation now. Try again later.
Articles 1–20